Sign in

CIK 0001622229

  • Large accelerated filer

Cogent Biosciences, Inc.

Sign in to watch
Ticker
COGT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
465308248
Phone
+1 617-945-5576
Business address
180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
Former names
Unum Therapeutics Inc., Unum Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,689,493
in 1 filing, $1.7M under 10b5-1 plans

Net −$1,689,493. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Morris Arlene −$1.7M Director sold 100% of stake
Date Insider Transaction Shares Price Value Owned after
2019-06-14 PEREZ ROBERT J Director Grant or award · Stock Option (Right to Buy) +7,131 $1.67 $12K 7,131
2019-04-01 PEREZ ROBERT J Director Grant or award · Stock Option (Right to Buy) +4,369 $2.72 $12K 4,369
2019-01-02 PEREZ ROBERT J Director Grant or award · Stock Option (Right to Buy) +4,397 $2.70 $12K 4,397
2018-10-01 PEREZ ROBERT J Director Grant or award · Stock Option (Right to Buy) +1,910 $6.22 $12K 1,910
2018-07-26 PEREZ ROBERT J Director Grant or award · Stock Option (Right to Buy) +1,361 $8.72 $12K 1,361

Page 1 of 1 · 5 trades